Claus André Frank Rentel

Title: The Innovations of Claus André Frank Rentel

Introduction

Claus André Frank Rentel is an accomplished inventor based in San Marcos, California. He has made significant contributions to the field of analytical chemistry, particularly in the detection and quantification of impurities in oligonucleotides. His innovative methods have the potential to enhance the accuracy and efficiency of various biochemical analyses.

Latest Patents

Rentel holds a patent for "Methods for detection, identification and quantification of impurities." This patent describes a method that involves introducing a sample containing a plurality of oligonucleotides into an ion pair high-performance liquid chromatography column. The method allows for the separation of oligonucleotides, their elution from the column, and subsequent quantification using mass spectrometry. Notably, the method ensures that co-eluting oligonucleotides, which differ in mass by no more than 20%, can be effectively analyzed.

Career Highlights

Claus André Frank Rentel is associated with Isis Pharmaceuticals, Inc., where he applies his expertise in analytical methods. His work focuses on improving the detection and quantification processes in biochemical research, contributing to advancements in the pharmaceutical industry.

Collaborations

Rentel collaborates with notable colleagues, including Christine C Kurata and Daniel C Capaldi. These partnerships enhance the research and development efforts at Isis Pharmaceuticals, fostering innovation in the field.

Conclusion

Claus André Frank Rentel's contributions to the field of analytical chemistry through his patented methods demonstrate his commitment to advancing scientific research. His work continues to impact the pharmaceutical industry positively.